Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Human Longevity: Why older individuals in poorer nations outlive those in wealthier nations

Project description

How older adults thrive in lower-income nations

In poorer nations, people generally have shorter lifespans due to disparities in healthcare, living conditions, nutrition, and exposure to infectious diseases. However, there are also cases of older adults in low- and middle-income countries (LMICs) living longer than their peers in wealthier nations. The ERC-funded LONGEVOUS project investigates this puzzle by examining why later-life survival appears stronger in certain LMICs. It will also explore how different environments shape ageing and health. The project aims to deepen global understanding of longevity. The goal is to reshape mortality theories by highlighting the resilience developed under challenging conditions. The findings will offer new insights into how people age across varied settings.

Objective

Individuals in poorer nations generally live shorter lives than their counterparts in wealthier nations. Paradoxically, as people age, an intriguing reversal of this pattern emerges, with older individuals in certain low- and middle-income countries (LMICs) outliving those in high-income countries (HICs). Why do older people in LMICs outlive those in HICs? Why does the later-life survival advantage only occur for some LMICs? Answering these pressing questions is critical for addressing the current and future impact of aging societies and for advancing theories of the mortality transition that do not yet consider the diversity of aging experiences worldwide.

LONGEVOUS has three ambitious goals and bold theoretical thrusts: (A) to assess the theoretical framework that explains the paradoxical later-life survival advantage in LMICs, (B) to assess the empirical mechanism behind low mortality at older ages in LMICs, and (C) to investigate whether this unexpected mortality paradox also emerges in terms of health outcomes. Project A tests the theory that adverse conditions over the life course create a group of robust individuals in later life. Project B develops a novel method for estimating mortality at older ages in certain LMICs, where the poor quality of age data remains unresolved and prevents us from testing mortality theories. Project C adds the health component to better understand country disparities in mortality at older ages. LONGEVOUS not only opens new perspectives for longevity research but also represents an unprecedented effort to conduct the most comprehensive study to date of the factors that shape mortality at older ages in LMICs.

LONGEVOUS will use a combination of several demographic and statistical methods, and multiple data sources, including censuses, record linkage studies, and longitudinal health data. The benefit of LONGEVOUS is clear: a ground-breaking paradigm shift in our understanding of later-life survival on a global scale.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Net EU contribution
€ 1 499 942,00
Address
HOFGARTENSTRASSE 8
80539 MUNCHEN
Germany
Region
Berlin Berlin Berlin
Activity type
Research Organisations
Links
Total cost
€ 1 499 942,00

Beneficiaries (1)